6 hours ago
SELLAS Life Sciences (SLS) Stock Surges Over 200% After Phase 3 Leukemia Vaccine Win
TLDR SELLAS Life Sciences (SLS) stock jumped more than 200% on Tuesday after positive Phase 3 REGAL results. Its cancer vaccine GPS cut the risk of death by 41% in acute myeloid leukemia patients. Median survival was 24.0 months with GPS versus 14.7 months for the control group. The company plans to meet the FDA [...]
The post SELLAS Life Sciences (SLS) Stock Surges Over 200% After Phase 3 Leukemia Vaccine Win appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Vertiv Holdings (VRT) Stock: Expands 800 VDC Power Systems for AI Data Centers
- 1 hour ago
Coinbase CEO says AI agents will account for '99.9%' of transactions within a de...
- 1 hour ago
Penguin Solutions, Inc. (PENG) Stock: Unveils ClusterWareAI 13.3 for NVIDIA Vera...
- 2 hours ago
Ciena Corporation (CIEN) Stock: Hits New 800G Network Record With Internet2
- 2 hours ago
Predictions platform Kalshi complies with order to halt Trump mention contracts
